314
Views
9
CrossRef citations to date
0
Altmetric
Current clinical practice: Hematological Malignancy

Influence of Epstein–Barr virus infection in adult T-cell leukemia

, , , , , , , , & show all
Pages 154-162 | Published online: 18 Jul 2013

References

  • Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T cell leukemia: clinical and hematological features of 16 cases. Blood 1977; 50: 481–492.
  • Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, GalloRC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980; 77: 7415–7419.
  • Hinuma Y, Nagata K, Hanaoka M et al. Adult T cell leukemia: antigen in ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981; 78: 6476–6480.
  • Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterizationof retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982; 79: 2031–2035.
  • Wong-Staal F, Gallo RC. Human T-lymphotropic retroviruses. Nature 1985; 317: 385–403.
  • Uchiyama T. Human T cell leukemia virus type 1 (HTLV-1) and human diseases. Annu Rev Immunol 1997; 15: 15–37.
  • Manns A, Hisada M, La Grenada L. Human T-lymphotropic virustype 1 infection. Lancet 1999; 353: 1951–1958.
  • Franchini G. Molecular mechanisms of human T-cell leukemia/ lymphotropic virus type I infection. Blood 1995; 86: 3619–3639.
  • Sodroski JG, Rosen CA, Haseltine WA. Transacting transcrip-tional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Science 1984; 225: 381–385.
  • Tanaka A, Takahashi C, Yamaoka S, Hatanaka M. Oncogenic transformation by the tax gene of human T-cell leukemia virus type 1 in vitro. Proc Natl Acad Sci USA 1990; 87: 1071–1079.
  • Yoshida M. Multiple viral strategies of HTLV-1 for dysregulationof cell growth control. Annu Rev Immunol 2001; 19: 475–496.
  • Feuer G, Chen IS. Mechanism of human T-cell leukemia virus induced leukemogenesis. Biochim Biophys Acta 1992; 1114: 223–228.
  • Murphy EL, Hanchard B, Figueroa JP et al. Modeling the risk of adult T cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type 1. Int J Cancer 1989; 43: 250–253.
  • Yamamoto N, Matsumoto T, Koyanagi Y, Tanaka Y, Hinuma Y. Unique cell lines harbouring both Epstein-Barr virus and T-cell leukemia virus, established from leukaemia patients. Nature 1982; 299: 367–369.
  • Imai J, Hinuma Y. Epstein-Barr virus-specific antibodies on patients with adult T-cell leukemia (ATL) and healthy ATL virus-carriers. Int J Cancer 1983; 31: 197–200.
  • Tokunaga M, Imai S, Uemura Y, Tokudome T, Osato T. Epstein-Barr virus in adult T-cell leukemia/lymphoma. Am J Pathol 1993; 143: 1263–1268.
  • Ohtsubo H, Arima N, Matsushita K et al. Human T lymphotropic virus-type 1 Tax induction of CD21/Epstein-Barr virus receptor expression on T-cells and its significance in leukemogenesis of adult T cell leukemia. Exp Hematol 1997; 25: 1246–1252.
  • Miyagi J, Toda T, Uezato H et al. Detection of Epstein-Barr virusand human T-cell lymphotropic virus-type 1 in malignant nodal lymphoma, studied in Okinawa, subtropical area in Japan. Int J Hematol 2002; 75: 78–84.
  • Ohtsubo H, Arima N, Tei C. Epstein-Barr virus involvement in T-cell malignancy: significance in adult T-cell leukemia. Leuk Lymphoma 1999; 33: 451–458.
  • Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964; 702–703.
  • Pallensen G, Hamilton-Dutoit SJ, Rowe M, Young LS. Expression of Epstein-Barr virus latent gene products in tumor cells of Hodgkin's disease. Lancet 1991; 337: 320–322.
  • Mueller N, Evans A, Harris N et al. Hodgkin's disease and Epstein-Barr virus. N Engl J Med 1989; 320: 689–695.
  • Jaffe ES. Nasal-type NK/T cell lymphoma associated with Epstein-Barr virus. Histopathology 1995; 27: 581–583.
  • Young LS, Dawson CW, Clark D et al. Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 1988; 69; 1051–1065.
  • Kanagane H, Bhatia K, Gutierrez M et al. A syndrome of peripheral blood T-cell infection with Epstein-Barr virus (EBV) followed by EBV positive T-cell lymphoma. Blood 1989; 91: 2085–2091.
  • Ishikawa T, Imura A, Tanaka K, Shirane H, Okumura M, Uchiyama T. E-selectin and vascular cell adhesion molecule-1 mediate adult T-cell leukemia cell adhesion to endothelial cells. Blood 1993; 82: 1590–1598.
  • Tanaka Y, Hayashi M, Takagi S, Yoshie O. Differential transactivation of the intercellular adhesion molecule 1 gene promoter by Tax 1 and Tax 2 of human T-cell leukemia viruses. J Virol 1996; 70: 8508–8517.
  • Velentin H, Lemasson I, Hamaia S et al. Transcriptional activation of the vascular cell adhesion molecule-1 gene in T lymphocytes expressing human T-cell leukemia virus type 1 Tax protein. J Virol 1997; 71: 8522–8530.
  • Mori N, Murakami S, Oda S, Eto S. Human T-cell leukemia virus type 1 Tax induces intracellular adhesion molecule-1 expression in T cells. Blood 1994; 84: 350–351.
  • Tanaka Y, Fukudome K, Hayashi M, Takagi S, Yoshie O. Induction of ICAM-1 and LFA-3 by Taxi of human T-cell leukemia virus type 1 and mechanism of down regulation of ICAM-1 or LFA-1 in adult T-cell leukemia cell lines. Int J Cancer 1995; 60: 554–561.
  • Fukudome K, Furuse M, Fukuhara N. Strong induction of ICAM-1 in human T-cells transformed by human T-cell leukemia virus type 1 and depression of ICAM-1 or LFA-1 in adult T-cell-leukemia-derived cell lines. Int J Cancer 1992; 52: 418–427.
  • Rickinson AB, Kieff E. Epstein-Barr virus. In: Knipe DM, Howley PM (eds.) Fields' Virology. Vol 2. Philadelphia, PA: Lippincott Williams & Wilkins, 2001; 2575–2627.
  • Thorley-Lawson DA, Babcock GJ. A model for persistent infection with Epstein-Barr virus: the stealth virus of human B cells. Life Sci 1996; 5: 1433–1453.
  • Sandvej KB, Hamilton-Dutoit SJ, Pallesen G. Influence of Epstein-Barr virus encoded latent membrane protein 1 on the expression of CD23 antigen, ICAM-1 and LFA-3 in Hodgkin and Reed-Sternberg cells. A morphometric analysis. Leuk Lymphoma 1939; 9: 95–101.
  • Park HJ, So EY, Lee, CE. Interferon-gamma-induced factor binding to the interleukin-4-responsive element of CD23b promo-ter in human tonsillar mononuclear cells: role in transient up-regulation of the interleukin-4-induced CD23 mRNA. Mol Immunol 1998; 35(4): 239–247.
  • Braun M, Melchers I, Peter HH, Illges H. Human B and T lymphocytes have similar amounts of CD21 mRNA, but differ in surface expression of the CD21 glycoprotein. Int Immunol 1998; 10(8): 1197–1202.
  • Uchiyama T, Kamio M, Kodaka T et al. Leukemia cells from some adult T-cell leukemia patients proliferate in response to interleukin-4. Blood 1998; 72: 1182–1186.
  • Mori N, Yamashita U, Tanaka Y et al. Interleukin-4 induces proliferation of adult T-cell leukemia cells. Eur J Haematol 1993; 50: 133–140.
  • Shimoyama M. Diagnosis criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma. Br J Hematol 1991; 79: 428–437.
  • Kai C, Okada N. Expression of CR2 (C3d receptor) on the cell membranes of adult T cell leukemia. Jpn J Cancer Res 1988; 79: 805–808.
  • Kishihara Y, Furusyo N, Kashiwagi K et al. Human T lymphotropic virus type 1 infection influences hepatitis C virus clearance. J Infect Dis 2001; 184: 1114–1119.
  • Sherman KE, O'Brien J, Gutierrez AG et al. Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections. J Clin Microbiol 1993; 31: 2679–2682.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.